Ligelizumab in adolescents with chronic spontaneous urticaria: Results of a dedicated phase 2b randomized clinical trial supported with pharmacometric analysis.
Saved in:
| Title: | Ligelizumab in adolescents with chronic spontaneous urticaria: Results of a dedicated phase 2b randomized clinical trial supported with pharmacometric analysis. |
|---|---|
| Authors: | Staubach, Petra1 (AUTHOR), Alvaro‐Lozano, Montserrat2 (AUTHOR), Sekerel, Bulent Enis3 (AUTHOR), Maurer, Marcus4,5 (AUTHOR), Ben‐Shoshan, Moshe6 (AUTHOR), Porter, Miriam7 (AUTHOR), Hua, Eva8 (AUTHOR), Ji, Yan9 (AUTHOR), Burciu, Alis7 (AUTHOR), Savelieva, Marina7 (AUTHOR), Severin, Thomas7 (AUTHOR), Drollmann, Anton7 (AUTHOR) anton.drollmann@novartis.com, Bienczak, Andrzej7 (AUTHOR) |
| Source: | Pediatric Allergy & Immunology. Jul2023, Vol. 34 Issue 7, p1-11. 11p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 09056157 |
|---|---|
| DOI: | 10.1111/pai.13982 |
